"Pulmonary Surfactants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances and drugs that lower the SURFACE TENSION of the mucoid layer lining the PULMONARY ALVEOLI.
Descriptor ID |
D011663
|
MeSH Number(s) |
D27.505.954.796.600
|
Concept/Terms |
Pulmonary Surfactants- Pulmonary Surfactants
- Surfactants, Pulmonary
- Pulmonary Surfactant
- Surfactant, Pulmonary
|
Below are MeSH descriptors whose meaning is more general than "Pulmonary Surfactants".
Below are MeSH descriptors whose meaning is more specific than "Pulmonary Surfactants".
This graph shows the total number of publications written about "Pulmonary Surfactants" by people in this website by year, and whether "Pulmonary Surfactants" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2002 | 1 | 1 | 2 |
2003 | 0 | 2 | 2 |
2005 | 0 | 2 | 2 |
2006 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
2008 | 1 | 1 | 2 |
2010 | 0 | 1 | 1 |
2011 | 1 | 0 | 1 |
2012 | 2 | 1 | 3 |
2016 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Pulmonary Surfactants" by people in Profiles.
-
Sherman TI, Moya F, Simmons PD, Kurtz D, Shaffer TH. Parental preferences regarding administration of an animal-derived versus a synthetic medication to newborn infants. J Neonatal Perinatal Med. 2016; 9(1):7-14.
-
Wolfson MR, Wu J, Hubert TL, Gregory TJ, Mazela J, Shaffer TH. Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDS. Pediatr Res. 2012 Oct; 72(4):375-83.
-
Shaffer TH, Alapati D, Greenspan JS, Wolfson MR. Neonatal non-invasive respiratory support: physiological implications. Pediatr Pulmonol. 2012 Sep; 47(9):837-47.
-
Shaffer TH, Wolfson MR. Translational research: matching experimental models with therapeutic interventions. Pediatr Crit Care Med. 2012 May; 13(3):369-70.
-
Bhatia R, Shaffer TH, Hossain J, Fisher AO, Horner LM, Rodriguez ME, Penfil S, Theroux MC. Surfactant administration prior to one lung ventilation: physiological and inflammatory correlates in a piglet model. Pediatr Pulmonol. 2011 Nov; 46(11):1069-78.
-
Malur A, Baker AD, McCoy AJ, Wells G, Barna BP, Kavuru MS, Malur AG, Thomassen MJ. Restoration of PPAR? reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice. Am J Physiol Lung Cell Mol Physiol. 2011 Jan; 300(1):L73-80.
-
Wolfson MR, Funanage VL, Kirwin SM, Pilon AL, Shashikant BN, Miller TL, Shaffer TH. Recombinant human Clara cell secretory protein treatment increases lung mRNA expression of surfactant proteins and vascular endothelial growth factor in a premature lamb model of respiratory distress syndrome. Am J Perinatol. 2008 Nov; 25(10):637-45.
-
Chong E, Greenspan J, Kirkby S, Culhane J, Dysart K. Changing use of surfactant over 6 years and its relationship to chronic lung disease. Pediatrics. 2008 Oct; 122(4):e917-21.
-
Miller TL, Shashikant BN, Pilon AL, Pierce RA, Shaffer TH, Wolfson MR. Effects of recombinant Clara cell secretory protein (rhCC10) on inflammatory-related matrix metalloproteinase activity in a preterm lamb model of neonatal respiratory distress. Pediatr Crit Care Med. 2007 Jan; 8(1):40-6.
-
Kinniry P, Pick J, Stephens S, Jain D, Solomides CC, Niven R, Segal R, Christofidou-Solomidou M. KL4-surfactant prevents hyperoxic and LPS-induced lung injury in mice. Pediatr Pulmonol. 2006 Oct; 41(10):916-28.